Literature DB >> 26049772

Myofascial Head Pain.

César Fernández-de-Las-Peñas1.   

Abstract

Muscle nociception is mainly characterized by local tenderness and referred pain. The neurophysiological basis of muscle pain supports a role of sensitization mechanisms. From a clinical viewpoint, muscle pain is represented by the presence of myofascial trigger points (TrPs). Evidence suggests that TrPs are able to start a peripheral nociceptive mechanism and hence contributing to changes in the central nervous system. Several studies demonstrated that the referred pain elicited by TrPs reproduces the headache pattern in patients with tension-type headache (TTH), migraine, cervicogenic headache and, in some individuals, with cluster headache. In fact, sensitization of nociceptive pain pathways in the central nervous system due to prolonged nociceptive stimuli from TrPs seems to be responsible for the conversion of episodic to chronic TTH. In other headaches, TrPs may be able to stimulate the trigeminal nucleus caudalis and hence triggering a migraine or cluster headache attack. Proper treatment directed towards TrP inactivation has documented positive effects in individuals with these headaches; however, longitudinal studies are needed to further determine the role of TrPs in head pain.

Entities:  

Mesh:

Year:  2015        PMID: 26049772     DOI: 10.1007/s11916-015-0503-2

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  59 in total

1.  Cervicogenic headache caused by myofascial trigger points in the sternocleidomastoid: a case report.

Authors:  J K Roth; R S Roth; J R Weintraub; D G Simons
Journal:  Cephalalgia       Date:  2007-04       Impact factor: 6.292

Review 2.  Brain manifestation and modulation of pain from myofascial trigger points.

Authors:  David M Niddam
Journal:  Curr Pain Headache Rep       Date:  2009-10

Review 3.  Musculoskeletal physical outcome measures in individuals with tension-type headache: a scoping review.

Authors:  Jacques Abboud; Andrée-Anne Marchand; Karin Sorra; Martin Descarreaux
Journal:  Cephalalgia       Date:  2013-06-26       Impact factor: 6.292

4.  Myofascial disorders in the trochlear region in unilateral migraine: a possible initiating or perpetuating factor.

Authors:  César Fernández-de-Las-Peñas; Maria Luz Cuadrado; Robert D Gerwin; Juan A Pareja
Journal:  Clin J Pain       Date:  2006 Jul-Aug       Impact factor: 3.442

5.  Trigger point evaluation in migraine patients: an indication of peripheral sensitization linked to migraine predisposition?

Authors:  E P Calandre; J Hidalgo; J M García-Leiva; F Rico-Villademoros
Journal:  Eur J Neurol       Date:  2006-03       Impact factor: 6.089

6.  Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.

Authors:  R Norman Harden; Jerod Cottrill; Christine M Gagnon; Todd A Smitherman; Stephan R Weinland; Beverley Tann; Petra Joseph; Thomas S Lee; Timothy T Houle
Journal:  Headache       Date:  2008-10-24       Impact factor: 5.887

7.  Capsaicin-induced central sensitization evokes segmental increases in trigger point sensitivity in humans.

Authors:  John Z Srbely; James P Dickey; Leah R Bent; David Lee; Mark Lowerison
Journal:  J Pain       Date:  2009-12-16       Impact factor: 5.820

8.  The local and referred pain from myofascial trigger points in the temporalis muscle contributes to pain profile in chronic tension-type headache.

Authors:  César Fernández-de-Las-Peñas; Hong-You Ge; Lars Arendt-Nielsen; Maria Luz Cuadrado; Juan A Pareja
Journal:  Clin J Pain       Date:  2007 Nov-Dec       Impact factor: 3.442

9.  Predictor variables for identifying patients with chronic tension-type headache who are likely to achieve short-term success with muscle trigger point therapy.

Authors:  C Fernández-de-las-Peñas; J A Cleland; M L Cuadrado; J A Pareja
Journal:  Cephalalgia       Date:  2008-03       Impact factor: 6.292

10.  Reproduction of overall spontaneous pain pattern by manual stimulation of active myofascial trigger points in fibromyalgia patients.

Authors:  Hong-You Ge; Ying Wang; César Fernández-de-las-Peñas; Thomas Graven-Nielsen; Bente Danneskiold-Samsøe; Lars Arendt-Nielsen
Journal:  Arthritis Res Ther       Date:  2011-03-22       Impact factor: 5.156

View more
  11 in total

1.  [Migraine prophylaxis with trigger point therapy and lymphatic drainage : A pilot study].

Authors:  Delphine Yedikardachian; Stefan Quasthoff; Anita T Lechner; Albrecht Giuliani; Franz Fazekas
Journal:  Wien Med Wochenschr       Date:  2017-08-02

2.  OnabotulinumtoxinA injections in chronic migraine, targeted to sites of pericranial myofascial pain: an observational, open label, real-life cohort study.

Authors:  Danièle Ranoux; Gaelle Martiné; Gaëlle Espagne-Dubreuilh; Marlène Amilhaud-Bordier; François Caire; Laurent Magy
Journal:  J Headache Pain       Date:  2017-07-21       Impact factor: 7.277

3.  Relationship of active trigger points with related disability and anxiety in people with tension-type headache.

Authors:  María Palacios-Ceña; Matteo Castaldo; Kelun Wang; Antonella Catena; Paola Torelli; Lars Arendt-Nielsen; César Fernández-de-Las-Peñas
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

4.  Quantitative magnetic resonance imaging of the upper trapezius muscles - assessment of myofascial trigger points in patients with migraine.

Authors:  Nico Sollmann; Nina Mathonia; Dominik Weidlich; Michaela Bonfert; Sebastian A Schroeder; Katharina A Badura; Tabea Renner; Florian Trepte-Freisleder; Carl Ganter; Sandro M Krieg; Claus Zimmer; Ernst J Rummeny; Dimitrios C Karampinos; Thomas Baum; Mirjam N Landgraf; Florian Heinen
Journal:  J Headache Pain       Date:  2019-01-18       Impact factor: 7.277

5.  Local myalgia compared to myofascial pain with referral according to the DC/TMD: Axis I and II results.

Authors:  Orit Winocur-Arias; Pessia Friedman-Rubin; Kian Abu Ras; Larry Lockerman; Alona Emodi-Perlman; Tzvika Greenbaum; Shoshana Reiter
Journal:  BMC Oral Health       Date:  2022-02-04       Impact factor: 2.757

6.  Repetitive Neuromuscular Magnetic Stimulation for Pediatric Headache Disorders: Muscular Effects and Factors Affecting Level of Response.

Authors:  Corinna Börner; Jacob Staisch; Magdalena Lang; Ari Hauser; Iris Hannibal; Kristina Huß; Birgit Klose; Matthias F Lechner; Nico Sollmann; Florian Heinen; Mirjam N Landgraf; Michaela V Bonfert
Journal:  Brain Sci       Date:  2022-07-16

7.  Biofeedback in the prophylactic treatment of medication overuse headache: a pilot randomized controlled trial.

Authors:  Marialuisa Rausa; Daniela Palomba; Sabina Cevoli; Luana Lazzerini; Elisa Sancisi; Pietro Cortelli; Giulia Pierangeli
Journal:  J Headache Pain       Date:  2016-09-22       Impact factor: 7.277

8.  Association between Cervical Spondylosis and Migraine: A Nationwide Retrospective Cohort Study.

Authors:  Wang-Sheng Lin; Tung-Fu Huang; Tien-Yow Chuang; Cheng-Li Lin; Chia-Hung Kao
Journal:  Int J Environ Res Public Health       Date:  2018-03-25       Impact factor: 3.390

9.  Alleviation of migraine symptoms by application of repetitive peripheral magnetic stimulation to myofascial trigger points of neck and shoulder muscles - A randomized trial.

Authors:  Tabea Renner; Nico Sollmann; Michaela V Bonfert; Mirjam N Landgraf; Florian Heinen; Lucia Albers; Florian Trepte-Freisleder; Birgit Klose; Helene König; Sandro M Krieg
Journal:  Sci Rep       Date:  2020-04-06       Impact factor: 4.379

10.  Patients with episodic migraine show increased T2 values of the trapezius muscles - an investigation by quantitative high-resolution magnetic resonance imaging.

Authors:  Nico Sollmann; Paul Schandelmaier; Dominik Weidlich; Corinna Börner; Giada Urban; Magdalena Lang; Claus Zimmer; Dimitrios C Karampinos; Mirjam N Landgraf; Florian Heinen; Thomas Baum; Michaela V Bonfert
Journal:  Cephalalgia       Date:  2021-02-20       Impact factor: 6.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.